MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
CONMED Corporation Total Shareholders Equity 2011-2026 | CNMD
Annual Total Shareholders Equity CONMED Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.03 B | 963 M | 834 M | 746 M | 785 M | 709 M | 710 M | 662 M | 631 M | 581 M | 585 M | 581 M | 606 M | 607 M | 573 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.03 B | 573 M | 707 M |
Quarterly Total Shareholders Equity CONMED Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.01 B | 1 B | 978 M | 933 M | 882 M | 855 M | 796 M | 780 M | 752 M | 746 M | 716 M | 673 M | 790 M | 785 M | 756 M | 744 M | 726 M | 709 M | 709 M | 709 M | 709 M | 710 M | 710 M | 710 M | 710 M | 662 M | 662 M | 662 M | 662 M | 631 M | 631 M | 631 M | 631 M | 581 M | 581 M | 581 M | 581 M | 585 M | 585 M | 585 M | 585 M | 581 M | 581 M | 581 M | 581 M | 606 M | 606 M | 606 M | 606 M | 607 M | 607 M | 607 M | 607 M | 573 M | 573 M | 573 M | 573 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.01 B | 573 M | 683 M |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
1.52 B | $ 13.26 | 1.14 % | $ 1.79 B |  USA |
 |
BIOLASE
BIOL
|
-247 K | - | -13.19 % | $ 166 K | USA |
 |
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | USA |
 |
Delcath Systems
DCTH
|
111 M | $ 10.67 | 2.79 % | $ 382 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
43.2 M | $ 25.74 | 0.12 % | $ 218 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
2.35 M | $ 2.09 | 2.21 % | $ 1.27 M | USA |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | $ 3.36 | 1.05 % | $ 126 M |  France |
 |
Inspire Medical Systems
INSP
|
781 M | $ 57.19 | 1.87 % | $ 1.68 B | USA |
 |
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
1.2 B | $ 60.47 | 0.62 % | $ 3.3 B |  Britain |
 |
ClearPoint Neuro
CLPT
|
28 M | $ 11.24 | 0.54 % | $ 318 M | USA |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.61 | 0.7 % | $ 38 M | USA |
 |
Invacare Corporation
IVC
|
81.1 M | - | - | $ 24.7 M | USA |
 |
IRIDEX Corporation
IRIX
|
4.92 M | $ 1.07 | 3.88 % | $ 18.1 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Neovasc
NVCN
|
1.98 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
2.93 M | $ 2.08 | 0.2 % | $ 5.77 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
347 M | $ 15.41 | 2.32 % | $ 362 M | USA |
 |
Butterfly Network
BFLY
|
169 M | $ 4.89 | 1.98 % | $ 1.04 B | USA |
 |
Stryker Corporation
SYK
|
22.4 B | $ 307.2 | -2.52 % | $ 117 B | USA |
 |
TransMedics Group
TMDX
|
473 M | $ 101.25 | 0.46 % | $ 3.44 B | USA |
 |
GBS
GBS
|
3 M | - | -0.57 % | $ 7.12 M | USA |
 |
Tandem Diabetes Care
TNDM
|
155 M | $ 19.98 | 2.3 % | $ 1.36 B | USA |
 |
Globus Medical
GMED
|
4.57 B | $ 90.77 | 0.65 % | $ 12.3 B | USA |
 |
NanoVibronix
NAOV
|
33.5 M | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.75 B | $ 88.24 | -0.31 % | $ 3.07 B | USA |
 |
Vivos Therapeutics
VVOS
|
-1.49 M | $ 0.84 | 4.35 % | $ 8.63 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
10.3 B | $ 84.0 | 0.6 % | $ 49.1 B | USA |
 |
LENSAR
LNSR
|
-26 M | $ 5.21 | -0.38 % | $ 62.3 M | USA |
 |
Pulmonx Corporation
LUNG
|
54.1 M | $ 1.33 | 3.52 % | $ 54.1 M | USA |
 |
MiMedx Group
MDXG
|
257 M | $ 3.57 | 6.25 % | $ 528 M | USA |